Evidence map›Paper›PMID 38330178›Full record

ArticleBlood advances2024

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.

Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Matthew Collin, Jakob Passweg, Claude E Bulabois, Anjum Khan, Michael Loschi and 23 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 4 pooled it
25.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 4 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Article
  6. Myelodysplasia in VEXAS syndrome.Blood advances · 2026
    Review
  7. Article
  8. SomaticBlood neoplasia · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. VEXAS syndrome.Nature reviews. Disease primers · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Unmasking Vexas Syndrome: A Rare Case with Crescentic Glomerulonephritis.European journal of case reports in internal medicine · 2026
    Article
  18. Article
  19. [VEXAS syndrome].Zeitschrift fur Rheumatologie · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 9 countries.

Carmelo GurnariDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0001-6829-5544
Linda KosterEBMT Leiden Study Unit, Leiden, The Netherlands.
Laurien BaaijEBMT Leiden Study Unit, Leiden, The Netherlands.
Mael HeibligDepartment of Hematology, Centre Hospitalier Lyon Sud, Lyon, France.ORCID 0000-0003-1682-8657
Ibrahim Yakoub-AghaCHU de Lille, University of Lille, INSERM U1286, INFINITE, Lille, France.ORCID 0000-0003-4524-8782
Matthew CollinRVI Newcastle, Newcastle, United Kingdom.
Jakob PasswegUniversity Hospital of Basel, Basel, Switzerland.ORCID 0000-0001-7092-3351
Claude E BulaboisCHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
Anjum KhanYorkshire Blood & Marrow Transplant Program, Leeds, United Kingdom.ORCID 0000-0001-6432-6999
Michael LoschiCHU Nice, Hôpital de l`Archet I, Nice, France.ORCID 0000-0002-4460-5939
Fabrizio Carnevale-SchiancaCandiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Elena CrisàCandiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Daniela CaravelliCandiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Jürgen KuballDepartment of Haematology, University Medical Centre, Utrecht, The Netherlands.ORCID 0000-0002-3914-7806
Francesco SaraceniAzienda Ospedaliero Universitaria delle Marche, Ancona, Italy.ORCID 0000-0001-6500-9514
Attilio OlivieriAzienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Alessandro RambaldiDepartment of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.ORCID 0000-0002-3739-7502
Austin G KulasekararajKing's College Hospital, London, United Kingdom.ORCID 0000-0003-3180-3570
Patrick J HaydenDepartment of Haematology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
Manuela BadoglioEBMT Paris Study Unit, Paris, France.
Francesco OnidaASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy.
Christof ScheidUniversity of Cologne, Cologne, Germany.ORCID 0009-0007-6539-226X
Franco FranceschiniRheumatology and Clinical Immunology, ASST Spedali Civili of Brescia and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.ORCID 0000-0003-3678-6124
Arsène MekinianSorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Service de médecine interne et Inflammation-Immunopathology-Biotherapy Department, Paris, France.ORCID 0000-0003-2849-3049
Sinisa SavicDepartment of Clinical Immunology and Allergy, Leeds Teaching Hospitals, NHS Trust, Leeds, United Kingdom.ORCID 0000-0001-7910-0554
Maria Teresa VosoDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0002-6164-4761
Joanna Drozd-SokolowskaUniversity Clinical Centre, Medical University of Warsaw, Warsaw, Poland.
John A SnowdenDepartment of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.ORCID 0000-0001-6819-3476
Kavita RajUniversity College London Hospitals NHS Trust, London, United Kingdom.ORCID 0000-0002-8258-354X
Tobias AlexanderCharité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin, Germany.ORCID 0000-0003-1193-0097
Marie RobinHopital St. Louis, Paris, France.ORCID 0000-0003-1388-9876
Raffaella GrecoUnit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.ORCID 0000-0002-6117-5328
Donal P McLornanUniversity College London Hospitals NHS Trust, London, United Kingdom.
Candiolo Cancer Institute · ITLeiden University · NLUniversity College London Hospitals NHS Foundation Trust · GBUniversity of Rome Tor Vergata · ITAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Nice · FRHôpital Lyon Sud · FRHumboldt-Universität zu Berlin · DEInserm · FRKing's College Hospital · GBLeeds Teaching Hospitals NHS Trust · GBMedical University of Warsaw · PLNewcastle College · GBNHS Blood and Transplant · GBOspedale Papa Giovanni XXIII · ITRoyal Hallamshire Hospital · GBSorbonne Université · FRTrinity College Dublin · IEUniversité Grenoble Alpes · FRUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationMyelodysplastic SyndromesSkin Diseases, GeneticHumansTransplantation, Homologous

Identifiers

PMID38330178
PMCPMC10955646
OpenAlexW4391658137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.